Capnocytophaga sputigena bacteremia in a patient with chronic lymphocytic leukemia

Ann Lab Med. 2014 Jul;34(4):325-7. doi: 10.3343/alm.2014.34.4.325. Epub 2014 Jun 19.

Authors

Jung-Ah Kim¹, Sung Kuk Hong², Eui-Chong Kim¹

Affiliations

¹ Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea.
² Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea. ; Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Bone Marrow Transplantation
Capnocytophaga / drug effects
Capnocytophaga / genetics
Capnocytophaga / isolation & purification*
Gram-Negative Bacterial Infections / complications
Gram-Negative Bacterial Infections / diagnosis*
Gram-Negative Bacterial Infections / drug therapy
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / complications
Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis*
Male
Microbial Sensitivity Tests
Penicillanic Acid / analogs & derivatives
Penicillanic Acid / pharmacology
Penicillanic Acid / therapeutic use
Piperacillin / pharmacology
Piperacillin / therapeutic use
RNA, Ribosomal, 16S / chemistry
RNA, Ribosomal, 16S / metabolism
Sequence Analysis, RNA
Sequence Homology, Nucleic Acid
Tazobactam
Transplantation, Homologous
Treatment Outcome

Substances

Anti-Bacterial Agents
RNA, Ribosomal, 16S
Penicillanic Acid
Tazobactam
Piperacillin